Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Barra

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|August 7, 2015
Cardiac resynchronization therapy defibrillator at the end of battery life: in an era of economic uncertainty, do super-responders provide an opportunity for resource optimization?Sergio Barra, Sharad Agarwal
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 6, 2014
Is atrial fibrillation so common after supraventricular arrhythmia ablation as to require prophylactic treatment?Sergio Barra, Michael Griffith, Patrick Heck
European Heart Journal|January 20, 2023
Ventricular arrhythmias and sudden cardiac death in heart failure with mildly reduced or preserved ejection fraction: knowledge gapsVictor Waldmann, Sergio Barra, Eloi Marijon
International Journal of Cardiology|October 30, 2015
Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients?Sergio Barra, Rui Providencia, Sharad Agarwal
European Heart Journal|December 29, 2023
Amiodarone for atrial fibrillation: a dead man walking?Rui Providencia, Kishore Kukendra-Rajah, Sergio Barra
BMJ Case Reports|June 7, 2012
Non-Hodgkin's lymphoma presenting as a mediastinal mass in a 38-year-old patient with superior vena cava syndrome and extreme fatigue owing to left atrium and right ventricle outflow tract compression: the applicability of strain imagingSergio Barra, Pedro Gomes, Rui Providência, et al.
BMJ Case Reports|June 7, 2012
Thirteen square centimetre mass causing syncope in a patient with device related infective endocarditisSergio Barra, Flavia Semedo, Rui Providencia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 4, 2016
An individualized left ventricular lead-targeting strategy improves long-term survival of cardiac resynchronization therapy patients and influences the benefit of the implantable cardioverter-defibrillator: a long-term follow-up of the TARGET studySergio Barra, Emma Yu, Fakhar Khan, et al.
BMJ Case Reports|April 19, 2013
Cardiovascular disease: thinking beyond atherosclerosisLuis Manuel Vilardouro Paiva, Marco Costa, Sergio Barra, et al.
Arrhythmia & Electrophysiology Review|July 4, 2018
Premature Ventricular Complex-induced CardiomyopathyJorge G Panizo, Sergio Barra, Greg Mellor, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|August 7, 2015
Cardiac resynchronization therapy defibrillator at the end of battery life: in an era of economic uncertainty, do super-responders provide an opportunity for resource optimization?Sergio Barra, Sharad Agarwal
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 6, 2014
Is atrial fibrillation so common after supraventricular arrhythmia ablation as to require prophylactic treatment?Sergio Barra, Michael Griffith, Patrick Heck
European Heart Journal|January 20, 2023
Ventricular arrhythmias and sudden cardiac death in heart failure with mildly reduced or preserved ejection fraction: knowledge gapsVictor Waldmann, Sergio Barra, Eloi Marijon
International Journal of Cardiology|October 30, 2015
Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients?Sergio Barra, Rui Providencia, Sharad Agarwal
European Heart Journal|December 29, 2023
Amiodarone for atrial fibrillation: a dead man walking?Rui Providencia, Kishore Kukendra-Rajah, Sergio Barra
BMJ Case Reports|June 7, 2012
Non-Hodgkin's lymphoma presenting as a mediastinal mass in a 38-year-old patient with superior vena cava syndrome and extreme fatigue owing to left atrium and right ventricle outflow tract compression: the applicability of strain imagingSergio Barra, Pedro Gomes, Rui Providência, et al.
BMJ Case Reports|June 7, 2012
Thirteen square centimetre mass causing syncope in a patient with device related infective endocarditisSergio Barra, Flavia Semedo, Rui Providencia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 4, 2016
An individualized left ventricular lead-targeting strategy improves long-term survival of cardiac resynchronization therapy patients and influences the benefit of the implantable cardioverter-defibrillator: a long-term follow-up of the TARGET studySergio Barra, Emma Yu, Fakhar Khan, et al.
BMJ Case Reports|April 19, 2013
Cardiovascular disease: thinking beyond atherosclerosisLuis Manuel Vilardouro Paiva, Marco Costa, Sergio Barra, et al.
Arrhythmia & Electrophysiology Review|July 4, 2018
Premature Ventricular Complex-induced CardiomyopathyJorge G Panizo, Sergio Barra, Greg Mellor, et al.
Pageof 4